A Study of the Safety, Tolerability and Preliminary Efficacy of DRM01B Topical Gel in Healthy Volunteers and Subjects With Acne Vulgaris

Trial Profile

A Study of the Safety, Tolerability and Preliminary Efficacy of DRM01B Topical Gel in Healthy Volunteers and Subjects With Acne Vulgaris

Completed
Phase of Trial: Phase I/II

Latest Information Update: 28 Oct 2016

At a glance

  • Drugs Olumacostat glasaretil (Primary)
  • Indications Acne vulgaris
  • Focus Proof of concept; Therapeutic Use
  • Sponsors Dermira
  • Most Recent Events

    • 07 Oct 2015 Results of this trial were presented at the European Academy of Dermatology and Venereology (EADV) Congress, according to a Dermira media release.
    • 07 Oct 2015 Results published in a Dermira media release.
    • 29 Sep 2015 According to a Dermira media release, new data from this trial will be presented at the European Academy of Dermatology and Venereology (EADV) Congress 2015.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top